MEDICA 2022 and COMPAMED 2022 Witness Notable Increase in Participation and Booked Areas
|
By LabMedica International staff writers Posted on 13 Nov 2022 |

The international leading medical trade fair MEDICA (Düsseldorf, Germany), and COMPAMED, the leading international trade fair for suppliers from the medical technology industry, are being held in Düsseldorf, Germany from Monday to Thursday (14 to 17 November 2022). Compared to last year, when the first in-person event re-launched after the wholly digital meeting in 2020, both events have seen a notable increase in participation and booked presentation areas. Almost the entire trade fair area has been taken.
Both events combined are once again offering a professional audience a comprehensive overview of the newest medical products and services for modern treatment in doctors’ offices and clinics, including all relevant process steps in product development and product manufacturing. The scope of novelties being presented at MEDICA ranges from laboratory technology and equipment to physiotherapy and orthopedic technology, convenience goods and consumables, up to high-tech medical solutions (i.e. diagnostic imaging, robotics) and health IT applications.
Microengineering, innovative coatings and materials, sensors, packaging technology or complete processing of individual orders, too, are part of the main focus of COMPAMED in Halls 8a and 8b. The International Microtechnology Business Network IVAM will be organizing the COMPAMED HIGH-TECH FORUM as well as a product market geared towards microtechnology as part of COMPAMED. The goal of the session for internationalization “Europe meets USA – High-Tech for Medical Devices” is to strengthen the cooperation between players from component manufacture, device manufacture and users from Europe and the U.S. An evolving trend among suppliers which has been favored by the COVID-19 pandemic is microfluidics as a key technology for patient-centered applications of laboratory diagnostics.
Apart from this product area involving so-called “point-of-care” diagnostics, the pandemic has also given a certain “booster” to the digitalization of the health care system in many countries. This is where the digitally driven start-up scene profits, which offers many options to present themselves to investors and a professional medical audience. Of special note is the MEDICA START-UP PARK (in Hall 12), for example. The shared booth has established itself over the years as a central meeting point for business and networking, and this year, it again counts around 40 participants. One of them is the German start-up Thericon which sees itself as the first company to give operating theatres a type of imaging that has been compiled and visually assembled from several different sources. Visual representations of hitherto invisible tissue properties are presented together with standard colored images on a single monitor. This diagnostic information and its intuitive display aim to make faster and more precise surgical results possible. The company’s MEDICA START-UP PARK presentation explains how it works in detail. The scope of further news from start-ups stretches from a compact system for wireless monitoring of a fetus, new ophthalmoscopes as diagnostic aids for cancer or stroke, to a variety of solutions involving Artificial Intelligence (AI), for example for medical management of nutrition, creating electronic patient files, or even for pre-operative tests concerning the evaluation of cognitive disturbances.
Another special stage for start-ups is the MEDICA CONNECTED HEALTHCARE FORUM (also in Hall 12). The topics for the four-day forum program focus on applications for medical networks, on the health metaverse (VR/AR technologies), on AI and Big Data and also on robotics. Around a 100 chosen young companies will present their businesses on the forum stage, where the finals of the 11th MEDICA Start-up COMPETITION (14 Nov.) and the 14th Healthcare Innovation World Cup (13 Nov) will be among the highlights. A new addition to the MEDICA program in the midst of the physiotherapy themed segment is the MEDICA SPORTS HUB (in trade fair Hall 4). Throughout the duration of the trade fair, the professional audience is being invited to train and engage in a dialogue with some of the most successful Olympic athletes in German history: Heike Henkel (Olympic champion, world champion and world record holder in the high jump) and Lars Riedel (Olympic champion and multiple world champion in the discus). Short lectures by the Olympic athletes, talk sessions and also audience-participation sporting exercises have been planned to alternate every half hour on each day of the fair. The topics range from mental health, nutrition, team success to professional endurance training or even aspects of workplace health promotion.
Not only sports celebrities have announced their attendance at MEDICA 2022, the program of the forums and the parallel conferences also feature top-class speakers. For example, Federal Minister of Health Prof. Dr Karl Lauterbach will be taking part in the kick-off event of the 45th German Hospital Day (DKT), the annual leading event for the top management of German hospitals (14 Nov./CCD Ost). Stabilizing the financial situation of the public health insurers is one of the issues that will be addressed at the MEDICA ECON FORUM (in Hall 12), where Dr Andreas Gassen, Chairman of the National Association of Statutory Health Insurance Physicians (KBV) will also participate. The starting day (14 Nov.) will also offer exciting sessions, such as the one with Dr. Gottfried Ludewig, Senior Vice President T-Systems Health Industry, on the so-called "amazonisation" of the healthcare market by tech giants, including the question of the extent to which this development will also affect Germany. On the third day of the forum organized by Techniker Krankenkasse (16 Nov.), the North Rhine-Westphalian Minister for Labor, Health and Social Affairs, Karl-Josef Laumann, will be attending to address questions of future health policy in the Forum Dialogue. Also part of the MEDICA program will be the Conference on Disaster and Military Medicine DiMiMED and the MEDICA MEDICINE + SPORTS CONFERENCE for the international professional sports medicine and sports science scene.
“At MEDICA 2022, we will be welcoming more than 4,400 presenting companies. At COMPAMED 2022, there will be around 700. We consider this increase of 40% for booked areas and many different participants from 70 nations as a huge sign of the trust across borders that is being placed in both events,” said Christian Grosser, Director Health & Medical Technologies at Messe Düsseldorf, underscoring the importance of MEDICA and COMPAMED. “What the medical technology industry needs in turbulent times such as these are just these strong platforms for international exchange, joint ventures and business. Companies are seeing an increasing necessity to work jointly with their partners in supply and manufacturing to ensure delivery capacity in times when prices increase dramatically and construction parts are becoming sparse.”
Related Links:
MEDICA
Latest MEDICA 2022 News
- Bosch Demonstrates Vivalytic All-In-One PCR Analyzer at MEDICA 2022
- Biovendor Group Presents CLIA Solution for Complex Diagnostics at MEDICA 2022
- Diatron Exhibits Advanced Hematology and Clinical Chemistry Analyzers at MEDICA 2022
- Immundiagnostik AG Presents New PCR Test MutaPLEX RespiraScreen4_Diff_seqc at MEDICA 2022
- Eurotrol Presents the Future of Blood Gas Controls at MEDICA 2022
- Rhinomed Announces European Launch of Revolutionary New Swab for Testing Children for Respiratory Diseases

- Absology Exhibits POCT Immunoassay Analyzer with Testing Time of Five Minutes
- Cormay Diagnostics Introduces True 5+ DIFF Multi-Patented Hematology Solution at MEDICA 2022
- EDAN Takes its Solutions up a Notch at MEDICA 2022
- Bioneer Presents Near-Patient POC Molecular Diagnostic System at MEDICA 2022
- Rhinostics Features New RHINObot Automated Decapper at MEDICA 2022
- MP Biomedicals Exhibits Innovative POC, Screening and Confirmatory Tests at MEDICA 2022
- Oxford Immunotec Showcases Automated T-SPOT.TB Test at MEDICA 2022
- Boditech Highlights Automated Benchtop and Handheld Immunoassay Readers at MEDICA 2022
- Co-Diagnostics Introduces its CoPrimer Technology and Applications at MEDICA 2022
- Sentinel Diagnostics Presents New Fully Automated Sample to Result System for Diagnosis of Viral Infections
Channels
Clinical Chemistry
view channel
Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke
Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more
Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules
Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read moreMolecular Diagnostics
view channel
Rapid Genetic Test Aims to Shorten Brain Tumor Diagnosis Time
Brain tumors can be highly aggressive and difficult to treat, and The Brain Tumour Charity describes them as the biggest cancer killer of children and adults under 40. With more than 100 recognized tumor... Read more
New Oncology Assays Deliver Precise Molecular Counts with MRD-Grade Sensitivity
Precise molecular monitoring is central to managing hematologic malignancies, but traditional PCR workflows can limit sensitivity, multiplexing, and result clarity. Limited sample volumes and fragmented... Read moreHematology
view channel
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read moreImmunology
view channel
Blood Test Differentiates Bacterial and Viral Infections in Febrile Infants
Fever in infants younger than 3 months is treated as a medical emergency because infections can become life-threatening while the immune system is still developing. Emergency department teams must quickly... Read more
New Autoantibody Test Targets Pre-Symptomatic Type 1 Diabetes Screening
Type 1 diabetes is often first recognized only after substantial beta-cell destruction, sometimes presenting as diabetic ketoacidosis. Population-scale screening could identify children at elevated risk... Read moreMicrobiology
view channel
One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens
Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more
FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures
Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more
New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment
Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read morePathology
view channel
New AI Model Maps Where Glioblastoma Could Return After Surgery
Glioblastoma is the most common malignant brain tumor in adults and the most lethal, with median survival of about 17 months after diagnosis. Even after surgeons remove all visible tumor and patients receive... Read more
Multimodal AI Supports Prostate Cancer Risk Assessment Across Diverse Cohorts
Artera’s (Los Altos, CA, USA) multimodal artificial intelligence (MMAI) platform is being featured in five abstracts at the American Society for Radiation Oncology (ASTRO) 2026 Annual Meeting.... Read moreTechnology
view channel
New Automation Workflow Streamlines NGS Library Preparation for High-Volume Labs
Demand for next-generation sequencing (NGS) continues to rise as laboratories process growing sample volumes, yet library preparation remains labor-intensive and a frequent source of variability.... Read more
ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read moreIndustry
view channel
Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection
Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Mayo Clinic Laboratories and Pathology Asia Expand Genomic Testing Across Asia-Pacific
Mayo Clinic Laboratories and Pathology Asia Holdings (PAH), together with subsidiary LifeStrands Genomics, announced a strategic investment and collaboration focused on expanding access to advanced diagnostics... Read more








